{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:15:51Z","timestamp":1791918951239,"version":"4.3.4"},"reference-count":11,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JHD"],"published-print":{"date-parts":[[2020,6,5]]},"DOI":"10.3233\/jhd-200002","type":"journal-article","created":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T10:50:42Z","timestamp":1585911042000},"page":"185-197","source":"Crossref","is-referenced-by-count":70,"title":["Huntington\u2019s Disease Clinical Trials Corner: April 2020"],"prefix":"10.1177","volume":"9","author":[{"given":"Filipe B.","family":"Rodrigues","sequence":"first","affiliation":[{"name":"UCL Huntington\u2019s Disease Centre, UCL Queen Square Institute of Neurology, University College London, UK"},{"name":"Laboratory of Clinical Pharmacology and Therapeutics, Faculdade de Medicina, Universidade de Lisboa, PT, Portugal"},{"name":"Instituto de Medicina Molecular, Lisbon, PT, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J.","family":"Wild","sequence":"additional","affiliation":[{"name":"UCL Huntington\u2019s Disease Centre, UCL Queen Square Institute of Neurology, University College London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"issue":"3","key":"10.3233\/JHD-200002_ref3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3233\/JHD-170262","article-title":"Clinical Trials Corner: September 2017","volume":"6","author":"Rodrigues","year":"2017","journal-title":"J Huntingtons Dis"},{"key":"10.3233\/JHD-200002_ref6","unstructured":"Wave Life Sciences Announces Topline Data and Addition of Higher Dose Cohort in Ongoing Phase 1b\/2a PRECISION-HD2 Trial in Huntington\u2019s Disease [press release]. 2019."},{"issue":"4","key":"10.3233\/JHD-200002_ref7","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.ymthe.2018.02.002","article-title":"Translation of MicroRNA-Based Huntingtin-Lowering Therapies from Preclinical Studies to the Clinic","volume":"26","author":"Miniarikova","year":"2018","journal-title":"Mol Ther"},{"issue":"11","key":"10.3233\/JHD-200002_ref9","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1002\/jnr.24111","article-title":"Triheptanoin for the treatment of brain energy deficit: A 14-year experience","volume":"95","author":"Mochel","year":"2017","journal-title":"Journal of Neuroscience Research"},{"issue":"9","key":"10.3233\/JHD-200002_ref10","first-page":"1","article-title":"Meta-research metrics matter: Letter regarding article \u201cIndirect tolerability comparison of Deutetrabenazine and Tetrabenazine for Huntington disease\u201d","volume":"4","author":"Rodrigues","year":"2017","journal-title":"J Clin Mov Disord"},{"issue":"4","key":"10.3233\/JHD-200002_ref11","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1002\/mdc3.12483","article-title":"Tetrabenazine Versus Deutetrabenazine for Huntington\u2019s Disease: Twins or Distant Cousins?","volume":"4","author":"Rodrigues","year":"2017","journal-title":"Movement Disorders Clinical Practice"},{"key":"10.3233\/JHD-200002_ref12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40734-017-0051-5","article-title":"Indirect tolerability comparison of Deutetrabenazine and Tetrabenazine for Huntington disease","volume":"4","author":"Claassen","year":"2017","journal-title":"J Clin Mov Disord"},{"issue":"1","key":"10.3233\/JHD-200002_ref13","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3233\/JHD-189001","article-title":"Huntingtons Disease Clinical Trials Corner: February 2018","volume":"7","author":"Rodrigues","year":"2018","journal-title":"Journal of Huntington\u2019s Disease"},{"issue":"3","key":"10.3233\/JHD-200002_ref14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3233\/JHD-189003","article-title":"Huntington\u2019s Disease Clinical Trials Corner: August 2018","volume":"7","author":"Rodrigues","year":"2018","journal-title":"J Huntingtons Dis"},{"issue":"1","key":"10.3233\/JHD-200002_ref15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3233\/JHD-190001","article-title":"Huntington\u2019s Disease Clinical Trials Corner: January 2019","volume":"8","author":"Rodrigues","year":"2019","journal-title":"Journal of Huntington\u2019s Disease"},{"issue":"3","key":"10.3233\/JHD-200002_ref16","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3233\/JHD-199003","article-title":"Huntington\u2019s Disease Clinical Trials Corner: June 2019","volume":"8","author":"Rodrigues","year":"2019","journal-title":"J Huntingtons Dis"}],"container-title":["Journal of Huntington's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JHD-200002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:51:01Z","timestamp":1777452661000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JHD-200002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,5]]},"references-count":11,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jhd-200002","relation":{},"ISSN":["1879-6397","1879-6400"],"issn-type":[{"value":"1879-6397","type":"print"},{"value":"1879-6400","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,5]]}}}